ProCE Banner Activity

ROS1 Revealed: A Cancer Conversation on the Changing Tide of NSCLC Treatment

Slideset

Slides from a live cancer conversations webinar covering current best practices in the diagnosis and management of ROS1-altered NSCLC. 

Released: August 27, 2024

Expiration: August 26, 2025

Share

Faculty

Jessica J Lin

Jessica J Lin, MD

Attending Physician
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Alice Shaw

Alice Shaw, MD, PhD

Chief, Strategic Partnerships
Attending Physician, Thoracic Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol-Myers Squibb.

Bristol Myers Squibb